CTNNB1 research hub

Study of L-dopa Treatment in Patients With a Neurodevelopmental Disorder (CTNNB1 Gene)

This study is looking at whether a medicine called L-dopa can help children aged 1 to 15 with a rare genetic condition called CTNNB1 syndrome. This condition affects development, movement, and learning. Researchers want to see if L-dopa can improve symptoms.